Search
Search
Marc R. Bloomenstein, OD, FAAO
Show Description +
How could a development in dry eye treatment affect a physician’s ability to treat patients in the future? In this episode of Collaborative Corner, Marc Bloomenstein, OD, looks at Tyrvaya—an FDA-approved nasal spray to treat dry eye disease. With Tyrvaya’s ability to produce natural tears while still offering the flexibility of artificial tears, Dr. Bloomenstein questions how this product could lead to the breakthrough of new mechanisms of action to treat dry eye disease and improve patients’ quality of life.
Posted: 11/22/2021
Marc R. Bloomenstein, OD, FAAO
How could a development in dry eye treatment affect a physician’s ability to treat patients in the future? In this episode of Collaborative Corner, Marc Bloomenstein, OD, looks at Tyrvaya—an FDA-approved nasal spray to treat dry eye disease. With Tyrvaya’s ability to produce natural tears while still offering the flexibility of artificial tears, Dr. Bloomenstein questions how this product could lead to the breakthrough of new mechanisms of action to treat dry eye disease and improve patients’ quality of life.
Posted: 11/22/2021
Please log in to leave a comment.